期刊文献+

Anti-CD20-scFv-IgGFc基因修饰T细胞诱导Raji细胞凋亡的研究

Anti-CD20-scFv-IgGFc Anchored Human T Lymphocytes Induced Raji Cells Apoptosis
下载PDF
导出
摘要 背景与目的:研究重组anti-CD20-scFv-IgGFc的pLNCX质粒转染T淋巴细胞后,用锚定的T细胞杀伤Raji细胞,观察其诱导Raji细胞凋亡的能力。材料与方法:重组质粒通过脂质体转染至逆转录病毒包装的PA317细胞中,600μg/ml的G418筛选3周后,用PA317细胞培养液感染的外周血T细胞和T细胞分别去杀伤等量的Raji细胞,于不同时间点用流式细胞仪检测Raji细胞Annexin Ⅴ和Bcl-2的阳性率。结果:流式细胞仪检测发现在24h内,CD20阳性的Raji细胞上Annexin Ⅴ阳性率明显高于对照组,Bcl-2的阳性表达率较对照组明显降低。结论:含anti-CD20-scFv-IgGFc重组子基因修饰的T细胞在数小时内就可引起Raji细胞发生凋亡,其早期凋亡可能通过启动Annexin Ⅴ,同时通过抑制Bcl-2的表达而加快Raji细胞凋亡达到靶向杀伤的作用。 BACKGROUND & AIM: By transfecting the CD20-scFv-IgGFc recombinant pLNCX plasmid into T lymphocytes and employing the anchored T lymphocytes to attack the Raji lymphoma cells in vitro, to explore the capability of the anchored T lymphocytes in inducing apoptosis of Raji cells. MATERIALS AND METHODS: Recombinant plasmid was transfected into retrovirus-packed PA317 cell lines with lipofectamine reagent, and then the growth of the trancfectants were selected in a medium supplemented with G418(600μg/ml) for 3 weeks. Raji cells were attacked by T lymphocytes with and without transfected PA317 supematant. The Annexin V and Bcl-2 positive rates in Raji cells at different times were monitored by flow cytometry. RESULTS: The expressions of Annexin V and Bcl-2 in CD20 ^+ Raji cells were obviously different to the control group within 24 hours. CONCLUSION: Anti-CD20-scFv-IgGFc modified T cells could provoke Raji cells apoptosis within several hours. Annexin V may initiate Raji early apoptosis, and meanwhile genetically modified T cells could inhibit Bcl-2 expression of Raji cells to its speed up its apoptosis.
出处 《癌变.畸变.突变》 CAS CSCD 2007年第4期290-293,共4页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 浙江省自然科学基金项目(302781)
关键词 淋巴瘤 CD20 免疫治疗 lymphoma CD20 immunotherapy
  • 相关文献

参考文献9

  • 1Johnson P,Kemmiem G.The mechanism of action of riuximab in the elimination of tumor cells[J].Sem in oncol,2003,30(1):3-8.
  • 2Manches O,Liu G,Chaperot L,et al.In vitro mechanism of action of rituximab on primary.non-Hodgkin lymphomas[J].Blood,2003,101(3):949-954.
  • 3赖增祖,熊冬生,范冬梅,许元富,刘汉芝,彭晖,朱祯平,杨纯正.抗CD20嵌合Fab′片段对B淋巴瘤细胞的生长抑制作用[J].科学通报,2001,46(1):61-65. 被引量:4
  • 4Glimcber LH,Kim KF,Green I,et al.In antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex restricted fashion to antigen-reaction T cells[J].J exp med,1982,155(2):445-459.
  • 5Bird RE,Hardman KD,Facobson FW,et al.Single-chain antigen-binding protein[J].Science,1998,242(4877):423-426.
  • 6Jazirehei AR,Huerta-Yepez S,Cheng G,et al.Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa} B signaling pathway in non-Hodgkin's lymphoma B-cell lines:role in sensitization to chemotherapeutic drug-induced apoptosis[J].Cancer Res,2005,65(1):264-276.
  • 7Alas S,Emmanouilides C,Bonavida E.Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis[J].Clin Cancer Res,2001,7(3):709-723.
  • 8Shan D,Ledbetter JA,Press OW,et al.Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies[J].Blood,1998,91(5):1644-1652.
  • 9Daming S,Oliver WP,Theca T,et al.Characterization of scfv-Ig constructs generated from the anti-CD20 mAb IF5 using linker peptides of varying lengths[J].J of Inmmunology,1999,162(11):6589-6595.

二级参考文献5

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部